I 
118TH CONGRESS 
2D SESSION H. R. 10135 
To improve the quality, appropriateness, and effectiveness of diagnosis in 
health care, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
NOVEMBER 15, 2024 
Mr. BEYER (for himself, Mr. VAN DREW, and Ms. SCHRIER) introduced the 
following bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To improve the quality, appropriateness, and effectiveness 
of diagnosis in health care, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Improving Diagnosis 
in Medicine Act of 2024’’. 
SEC. 2. RESEARCH PROGRAM TO IMPROVE DIAGNOSTIC 
SAFETY AND QUALITY. 
Part B of title IX of the Public Health Service Act 
(42 U.S.C. 299b et seq.) is amended by adding at the end 
the following: 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
‘‘SEC. 918. RESEARCH PROGRAM TO IMPROVE DIAGNOSTIC 
SAFETY AND QUALITY. 
‘‘(a) IN GENERAL.—The Director shall establish a 
comprehensive program of research and quality improve-
ment to— 
‘‘(1) assess and understand diagnostic errors, 
including diagnostic delays, and how to eliminate 
common failures in the diagnostic process that lead 
to significant patient harm; and 
‘‘(2) identify, develop, implement, and dissemi-
nate evidence-based strategies and best practices for 
improving diagnostic quality, safety, and health care 
value. 
‘‘(b) ACTIVITIES.—The program established under 
subsection (a) shall include the following: 
‘‘(1) CONTINUUM OF RESEARCH.—A portfolio 
of conducted and supported activities that is con-
sistent with the research, implementation, and dis-
semination activities of the Center for Quality Im-
provement and Patient Safety, as described in sec-
tion 933, including— 
‘‘(A) investigator-initiated research to as-
sess diagnostic errors and identify improved 
methods to prevent errors and the harm errors 
cause; 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(B) translation and synthesis of research 
findings and development of tools for imple-
menting prevention strategies into practice; 
‘‘(C) implementation research to refine evi-
dence-based tools for improving diagnostic proc-
esses and effectively integrate these solutions 
into practice; and 
‘‘(D) dissemination to promote implemen-
tation of effective methods, strategies, and tools 
for wide-scale improvement, including identi-
fying where digital- and artificial intelligence- 
enabled tools could be beneficial. 
‘‘(2) RESEARCH CENTERS OF DIAGNOSTIC EX-
CELLENCE.—Consistent with section 911(b), the 
health care improvement research centers described 
in such section shall link research directly with clin-
ical practice in geographically diverse locations 
throughout the United States, and may include— 
‘‘(A) academic medical and institutional re-
search centers that combine demonstrated mul-
tidisciplinary expertise in diagnostic outcomes 
or quality improvement research with linkages 
directly or through national, State or local 
stakeholder partner organizations to relevant 
sites of care; and 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(B) provider-based research networks, in-
cluding plan, facility, or delivery system sites of 
care (especially primary care), that can evaluate 
outcomes and evaluate and promote quality im-
provement approaches. 
‘‘(3) FINANCIAL
ASSISTANCE.—The Director 
may provide financial assistance to assist in meeting 
the costs of planning and establishing new centers, 
as well as operating existing and new centers, pursu-
ant to section 902(c). 
‘‘(4) STAKEHOLDER
ENGAGEMENT.—The Di-
rector shall identify and enter into a supporting 
agreement, pursuant to a grant or contract, with a 
nonprofit entity that convenes a coalition of diverse 
health care stakeholders for the purpose of— 
‘‘(A) raising attention to diagnostic safety 
and quality concerns; 
‘‘(B) facilitating learning, adoption, and 
dissemination of effective quality improvement 
interventions; and 
‘‘(C) catalyzing novel actions by individual 
member organizations to reduce harms from di-
agnostic error and improve patient outcomes. 
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.— 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(1) IN GENERAL.—To carry out this section, 
there are authorized to be appropriated $30,000,000 
for fiscal year 2025, $35,000,000 for fiscal year 
2026, $40,000,000 for fiscal year 2027, and 
$45,000,000 for each of fiscal years 2028 and 2029. 
‘‘(2) RESERVATION.—Of the amount appro-
priated under paragraph (1) for a fiscal year, 
$700,000 shall be allocated to carrying out the pur-
pose described in subsection (b)(4). 
‘‘(3) 
AVAILABILITY.—Amounts 
appropriated 
under this section shall remain available until ex-
pended.’’. 
SEC. 3. FELLOWSHIPS AND TRAINING GRANTS. 
(a) RUTH KIRSCHSTEIN AWARDS.—Section 487(a) of 
the Public Health Service Act (42 U.S.C. 288(a)) is 
amended by adding at the end the following: 
‘‘(5) For purposes of the program under this sub-
section, biomedical and behavioral research includes diag-
nostic safety and quality research.’’. 
(b) AHRQ PROGRAMS.—Section 902(b)(1) of the 
Public Health Service Act (42 U.S.C. 299a(b)(1)) is 
amended— 
(1) by inserting ‘‘and diagnostic safety and 
quality’’ after ‘‘subsection (a)’’; and 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
(2) by striking ‘‘under section 487(d)(3)’’ and 
inserting ‘‘for purposes of carrying out section 487’’. 
SEC. 4. QUALITY MEASURE DEVELOPMENT. 
Section 931(c)(2) of the Public Health Service Act 
(42 U.S.C. 299b–31(c)(2)) is amended— 
(1) 
by 
redesignating 
subparagraphs 
(B) 
through (J) as subparagraphs (C) through (K), re-
spectively; and 
(2) by inserting after subparagraph (A) the fol-
lowing: 
‘‘(B) diagnostic safety and quality;’’. 
SEC. 5. STANDARDIZED DATA FOR DIAGNOSIS RESEARCH 
AND IMPROVEMENT. 
Section 937(f) of the Public Health Service Act (42 
U.S.C. 299b–37(f)) is amended— 
(1) by striking ‘‘The Secretary’’ and inserting 
the following: 
‘‘(1) IN GENERAL.—The Secretary’’; and 
(2) adding at the end the following: 
‘‘(2) CONSULTATION WITH EXPERT PANEL.—In 
carrying out paragraph (1), the Secretary, in coordi-
nation with the Director, the Administrator of the 
Centers for Medicare & Medicaid Services, the Na-
tional Coordinator for Health Information Tech-
nology, the Director of the National Library of Med-
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS